BRCA1 and cancer: Cancer genome profiling tests, cancer BRCA1/2 genetic tests, and genetic counseling were accessed at 11.10% (range by prefecture: 0.0%–50.0%), 60.00% (0.0%–100.0%), and 33.30% (0.0%–72.4%) of DCCHs, respectively.